Loading...
XASX
CAN
Market cap1mUSD
Jul 09, Last price  
0.00AUD
1D
0.00%
1Q
-20.00%
IPO
-99.40%
Name

Cann Group Ltd

Chart & Performance

D1W1MN
XASX:CAN chart
P/E
P/S
0.21
EPS
Div Yield, %
Shrs. gr., 5y
29.80%
Rev. gr., 5y
82.92%
Revenues
13m
-13.79%
13,7426,6628,421605,6462,607,941647,2224,293,0006,411,00013,777,00015,373,00013,253,000
Net income
-22m
L-56.39%
-4,176,446-1,462,011-2,588,445-4,725,857-10,926,317-16,937,387-25,103,000-26,468,000-33,790,000-51,242,000-22,345,000
CFO
-10m
L-36.50%
-642,737-1,246,727-2,298,851-3,754,511-7,422,547-17,618,574-20,830,000-20,433,000-22,835,000-15,185,000-9,643,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.
IPO date
May 04, 2017
Employees
40
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT